EFNB2 and neoplasm: This is likely due to the contribution of tumor-promoting effects by ephrinB2 signaling on the cancer cell, as it is only when both cancer cell and vascular ephrinB2 are knocked out that significant anti-angiogenic effect and meaningful growth delay are observed in vivo.